1. Pitout JDD, Nordmann P, Poirel L (2015) Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 59(10):5873–5884
2. Zhang W, Guo Y, Li J, Zhang Y, Yang Y, Dong DETAL (2018) In vitro and in vivo bactericidal activity of ceftazidime-avibactam against carbapenemase-producing Klebsiella pneumoniae. Antimicrob Resist Infect Control 7(142):1–9
3. Bakthavatchalam YD, Anandan S, Veeraraghavan B (2016) Laboratory detection and clinical ımplication of oxacillinase-48 like carbapenemase: the hidden threat. J Glob Infect Dis 8(1):41–50
4. Sader HS, Castanheira M, Shortridge D, Mendes RE, Flamm RK (2017) Antimicrobial activity of ceftazidime-avibactam tested against multi drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa isolates from U.S. medical centers, 2013 to 2016. Antimicrob Agents Chemother 61:e01045–e1117
5. Lee CR, Lee JH, Park KS, Kim YB, Jeong BC, Lee SH (2016) Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front Microbiol 13(7):895